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Abstract
Large-scale proliferation and multi-lineage differentiation capabilities make neural stem cells (NSCs) a
promising renewable source of cells for therapeutic applications. However, the practical application for
neuronal cell replacement is limited by heterogeneity of NSC progeny, relatively low yield of neurons,
predominance of astrocytes, poor survival of donor cells following transplantation and the potential for
uncontrolled proliferation of precursor cells. To address these impediments, we have developed a method for
the generation of highly enriched immature neurons from murine NSC progeny. Adaptation of the standard
differentiation procedure in concert with flow cytometry selection, using scattered light and positive
fluorescent light selection based on cell surface antibody binding, provided a near pure (97%) immature
neuron population. Using the purified neurons, we screened a panel of growth factors and found that bone
morphogenetic protein-4 (BMP-4) demonstrated a strong survival effect on the cells in vitro, and enhanced
their functional maturity. This effect was maintained following transplantation into the adult mouse striatum
where we observed a 2-fold increase in the survival of the implanted cells and a 3-fold increase in NeuN
expression. Additionally, based on the neural-colony forming cell assay (N-CFCA), we noted a 64 fold
reduction of the bona fide NSC frequency in neuronal cell population and that implanted donor cells showed
no signs of excessive or uncontrolled proliferation. The ability to provide defined neural cell populations from
renewable sources such as NSC may find application for cell replacement therapies in the central nervous
system.
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Abstract
Large-scale proliferation and multi-lineage differentiation capabilities make neural stem cells (NSCs) a promising renewable
source of cells for therapeutic applications. However, the practical application for neuronal cell replacement is limited by
heterogeneity of NSC progeny, relatively low yield of neurons, predominance of astrocytes, poor survival of donor cells
following transplantation and the potential for uncontrolled proliferation of precursor cells. To address these impediments,
we have developed a method for the generation of highly enriched immature neurons from murine NSC progeny.
Adaptation of the standard differentiation procedure in concert with flow cytometry selection, using scattered light and
positive fluorescent light selection based on cell surface antibody binding, provided a near pure (97%) immature neuron
population. Using the purified neurons, we screened a panel of growth factors and found that bone morphogenetic
protein-4 (BMP-4) demonstrated a strong survival effect on the cells in vitro, and enhanced their functional maturity. This
effect was maintained following transplantation into the adult mouse striatum where we observed a 2-fold increase in the
survival of the implanted cells and a 3-fold increase in NeuN expression. Additionally, based on the neural-colony forming
cell assay (N-CFCA), we noted a 64 fold reduction of the bona fide NSC frequency in neuronal cell population and that
implanted donor cells showed no signs of excessive or uncontrolled proliferation. The ability to provide defined neural cell
populations from renewable sources such as NSC may find application for cell replacement therapies in the central nervous
system.
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Introduction
Cell-based therapy in neurological diseases is an attractive
option, but presents a difficult challenge, given the diversity of
central nervous system (CNS) cell types, the complex and precise
interactions amongst them and the availability of appropriate
cellular sources. Sources for cell transplantation in the nervous
system includes fetal neural tissues [1,2,3], embryonic stem (ES)
cells [4,5], induced pluripotent stem (IPS) cells [6], neural stem
cells (NSCs) [7,8], non-neural somatic stem cells [9,10,11,12] or
even direct conversion of non-neural cells into neurons [13]. Each
of these cell types have the potential to replace cells lost to injury or
disease [14] or to modulate brain or spinal cord function [15]; with
each having their own advantages and disadvantages. Among the
available options, NSCs are a promising choice as they retain the
ability to generate a large number of cells from a relatively small
amount of starting tissue and express the capacity for multi-lineage
differentiation [16,17]. However, NSC progeny are a heteroge-
neous cell population that exhibit poor survival [18] and largely
differentiate into glia following implantation into the mature CNS
[8]. In addition, a small population of the NSC progeny may
retain a substantial proliferative potential [19,20]. These caveats
are further compounded by the poorly defined composition of cells
within a multi-lineage NSC culture and the need for well
characterized, highly purified cell phenotypes so as to reduce
variability in pre-clinical and clinical investigations.
To overcome these problems it is desirable to establish standard
reproducible methodologies to generate highly enriched or
relatively pure populations of cells. These cells can also be used
for screening assays to uncover agents or niche-related conditions
that enhance their survival, differentiation, neurite outgrowth and
integration into the pre- existing circuitry of the adult CNS. With
these aims in mind, and using cultured NSCs as a starting source
of cells, here we show that using the distinct morphological
characteristics of glial and neuronal cell populations, derived from
differentiating NSC progeny, an enriched population of immature
neurons can be isolated based solely on cell size and internal
complexity (i.e. forward and side scatter properties; FSC and
SSC). This enriched neuronal population contains a significant
reduction in contaminating stem and progenitor cells, as evidenced
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by the in vitro neurosphere and neural colony forming cell (N-CFC)
assays. Further purification (up to 97%) of the neuronal population
can be achieved by excluding O4 and A2B5-immunoreactive (IR)
cells (negative selection) or by positively selecting the PSA-NCAM-
IR cells within the FSClowSSClow cell population. Screening a
small panel of growth factors, we identified BMP-4 as a factor
supporting the survival and maturation of the purified immature
neuronal cells in vitro and following transplantation. Importantly,
implanted cells retained their neuronal phenotype and showed no
signs of excessive proliferative ability.
Development of similar methodologies for purifying astrocytes
and oligodendrocytes will provide the opportunity to deliver
defined populations of cells into the CNS with the intent of




Animals used in this study including adult male non obese
diabetic-severe combined immunodeficient (NOD-SCID) and
C57-BL6 wild type (Animal Resource Center, Nedlands, WA)
and doublecortin-GFP and Tau-GFP mice (from Dr. Helen
Cooper Laboratory, The University of Queensland, Australia)
were housed with unlimited access to food and water. The
University of Queensland Animal Ethics Committee approved all
experimental protocols in this study (Approval ID#QBI/173/06/
QBI).
Neural stem cell isolation, expansion and differentiation
Neural stem and progenitor cells from the ganglionic eminences
of E14 brains of C57-BL6 background (wild-type, doublecortin-
GFP and tau-GFP) mice were isolated and expanded using the
neurosphere assay [16,21] . Primary neurospheres were passaged
after 5–7 days using 0.05% trypsin-EDTA (Gibco, USA) and
plated at a density of 56104 cells /ml in mouse NeuroCult basal
NSC Medium plus mouse Neurocult NSC Proliferation Supple-
ments (Stem Cells Technologies, Vancouver, Canada) supple-
mented with 20 ng/ml EGF (BD Biosciences, San Jose, CA) in
NUNC tissue culture flasks in humidified 37uC incubator with 5%
CO2. To differentiate neural stem cells progeny, we employed the
method used by Scheffler et al [22] with some modifications.
Briefly, dissociated neurospheres from passage one to three were
plated at a high density (36105 cells/ml) in mouse NSC medium
containing 5% fetal calf serum (FCS) (Gibco), 20 ng/ml EGF,
10 ng/ml bFGF (Roche, Basel, Switzerland) and 2 mg/ml heparin
(Sigma) for 3–4 days. Subsequently, the medium was switched to
the same medium with 5% FCS but without any growth factors.
At this stage neuronal progenitors start to divide repetitively and
generate colonies of immature neurons (neuroblast cells) within 4
days. Hence we call this assay the NeuroBlast Assay (NBA) so as to
distinguish it from conventional differentiation methods.
Cell preparation and flow cytometry
Four days after switching to growth factor free medium,
neuroblast assay cultures were washed with phosphate-buffered
saline (PBS) and treated with pre-warmed trypsin-EDTA for 1–2
minutes in a 37uC incubator. An equal volume of trypsin inhibitor
(prepared as 0.014% w/v trypsin inhibitor (type I-S from soybean;
Sigma- Aldrich, St. Louis, MO) in HEPES-buffered minimum
essential medium (HEM), which consisted of minimum essential
medium (Invitrogen) and 16 mM HEPES (Sigma-Aldrich) was
used to quench trypsin activity. The cell suspension was
centrifuged at 700 rpm for 5 minutes. After resuspending in 2–
3 ml of NSC medium, cells were passed through a 40 mm cell
strainer (BD, Falcon, USA) to separate non-dissociated clumps.
Propidium Iodide (PI, Sigma, 500 mg/ml in PBS) was added at a
concentration of 1 ml/ ml of cell suspension to exclude dead cells
when analyzed by flow cytometry. To exclude contaminating cells,
and to have further neuronal enrichment, antibodies against the
oligodendrocyte maker O4 (Chemicon, monoclonal anti-IgM,
1:300) and bipotential glial cells marker A2B5 (Chemicon,
monoclonal anti-IgM, 1:300) were added to the cell suspension
for 30 mins at room temperature. For the direct isolation of
immature neuronal cells, anti-PSA-NCAM antibody (Chemicon,
monoclonal anti- IgM, 1:300) was added to the cell suspension,
and incubated for 30 min at room temperature. After washing
twice with basal medium, cells were resuspended in fresh medium
containing secondary antibody (Chemicon, goat anti-mouse IGM-
Alexafluor 633, 1:700) for 30 min at room temperature in the
dark. Alternatively, when sorting PSA-NCAM IR cells from the
O4/A2B5 double excluded cell population, Phycoerythrin (PE)
conjugated anti-PSA-NCAM antibody (Miltenyi biotec, USA) was
used at 10 ml/ 16106 cells in 100 ml of NSC medium for 10 mins
in the dark at 2–8uC. After washing twice in medium, cells were
resuspended in 2–3 ml of medium with PI, analyzed and sorted by
a FACS Vantage SE Diva (BD Biosciences, CA, USA), running
phosphate buffered saline (PBS) as the sheath fluid at 28 PSI
through a 90 mm nozzle. Differential pressure on the system was
adjusted such that sort trigger rates did not exceed 800 events/
second. Laser excitations for fluorescence measurements were
200 mW at 488 nm or 35 mW at 633 nm. Resulting data were
gated on bivariate displays, initially on forward and side scatter
pulse area, to exclude debris and unwanted cells, and then on side
scatter pulse width, versus side scatter pulse height to exclude
doublets or cell clumps. Subsequent gates were set to exclude dead
cells (PI positive cells) and select the cells, which represented the
different cell populations of interest and/or showed staining above
or below background. These sorted cells were collected in 15 ml
BD Falcon tubes containing NSC medium. After spinning and
performing a cell count, cells were plated at 16104 cells/well in
poly-l-ornithine (Sigma, USA) coated 96 well plates containing
mouse NSC medium alone or the medium supplemented
individually with growth factors (fetal calf serum (FCS) at 2%
and 10%, brain derived nerve growth factor (BDNF, human
recombinant, R&D system, USA) at 100 ng/ml, ciliary neuro-
trophic factor (CNTF, human recombinant, R&D system, USA) at
20 ng/ml, growth hormone (GH, human recombinant, R&D
system, USA) at 100 ng/ml, noggin (mouse recombinant, R&D
system, USA) at 200 ng/ml and BMP-4 (human recombinant,
R&D system, USA ) at 20 ng/ml).
Apoptosis assay
To further evaluate the survival effect of BMP4, sorted
immature neuronal cells were plated at a density of 46106 cells
in 5 ml of NSC medium supplemented with or without 20 ng/ml
of BMP-4 in T25 flasks. One day after sorting, cells were detached
from the culture flasks using trypsin-EDTA and either used for
Annexin-V assay (Molecular Probes) or fixed using cold 4%
paraformaldehyde (PFA, Sigma Aldrich, USA) and immuno-
stained for rabbit anti-active Caspase-3 (BD Biosciences, 1:500)
and b III-tubulin (Promega, 1:2000) to evaluate the rate apoptotic
cell death. Using BD LSR-II flow cytometer, the percentage of
total PI+ cells (dead or dying cells) and Annexin-V IR cells
(apoptotic cells) out of total live cells and the percentage of total
active Caspase-3 IR cells (apoptotic cells) out of total b III-tubulin
IR were calculated for both control and BMP4 treated cells.
Purification of Immature Neuronal Cells
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Immunofluorescence and microscopy
At different time point after sort, cultured cells were fixed for
20 min using cold 4% PFA and washed with PBS. The primary
antibody solution prepared at appropriate concentration in PBST
(PBS +0.1% Triton-X) with 10% normal goat serum (NGS,
Sigma-Aldrich) was added to each well of the 96 well plates and
incubated for 1 hour at room temperature, or overnight at 4uC.
Primary antibodies used in this study included rabbit polyclonal
antibodies against GFAP (DakoCytomation, 1:500), DARPP
(dopamine- and adenosine 3, 5-monophos- phate-regulated
phosphoprotein) -32 (Chemicon, 1:500), TH (Abcam, 1:500),
GAD 65/67 (Chemicon, 1:500), and ChAT (Chemicon, 1:100),
and mouse monoclonal antibodies against b III-tubulin (Promega,
1: 2000), O4 (Chemicon, 1:300), A2B5 (Chemicon, 1:300), Map2
(Chemicon, 1:300), Nestin (Chemicon, 1:200), PSA-NCAM
(Chemicon, 1:300), and NeuN (Chemicon, 1:150). Then, the
primary antibody was gently removed from the wells and the wells
were washed with PBS. Secondary antibodies were prepared at
appropriate concentrations in PBST (PBS +0.1% Triton-X) with
10% NGS, and were added at 50 ml/well and the plate was
incubated for 45 min at room temperature in the dark. Secondary
antibodies used in this study included Alexa fluor 568, Alexa fluor
488, Alexa fluor 633 conjugated goat anti mouse or anti rabbit
antibodies (all from Molecular Probes, 1:700). 49,-69 diamidino-2-
phenylindole (DAPI) (Molecular Probes, 1:1000) was also added to
the secondary antibody solution to label nuclei. Representative
pictures of each well (10–15 fields/ well) were taken using a
fluorescent microscope (Olympus IX-70) equipped with Canon
EOS digital camera and cell counts were performed and
calculated as a percentage of total cells counted, or mean absolute
number/ field of view.
Determining the frequency of neural stem/progenitor
cells in sorted cells
To evaluate sphere forming frequency, sorted cells from P1, P2
and the total population (P4) were counted and plated in 250 ml/
well of NSC medium supplemented with 20 ng/ml EGF in 96 well
plates (NUNC) at the density of 16104, 46103, and 56103 cells/
well respectively. Neurospheres greater than 50 mm were counted
7 days after plating and expressed as a percentage of total cells
plated.
To evaluate bona fide neural stem cells frequency, 16104 cells/
dish from P1, 46103 cells/dish from P2, and 56103 cells/dish
from the total population were plated in 35 mm cell culture dish
(NUNC) in 1.5 ml/ dish of serum-free neural colony forming cell
assay (N-CFCA) medium containing supplements as described in
the Neural Colony Forming Cell Assay kit (Stem Cell Technol-
ogies, Vancouver, Canada). 20 ng/ml EGF was used as a mitogen.
The culture was fed every 7 days with 60 ml / dish of the NSC
medium with EGF. Twenty-one days after plating, colonies were
counted, sized and the number of big colonies (greater than 2 mm)
was expressed as a percentage of total cells plated representing the
frequency of the bona fide neural stem cells [23,24].
Immunophenotyping and electrophysiological propeties
of sorted neuronal cells
Cells from the P1 population were plated at a density of
16105 cells/well on poly-l-ornithine (Sigma, USA) coated cover-
slips in mouse NSC medium supplemented with 20 ng/ml BMP-4,
astrocyte conditioned medium, and astrocyte conditioned medium
supplemented with 20 ng/ml of BMP-4. To prepare astrocyte
conditioned medium, NSC medium supplemented with 5% FCS
was added to a sister flask of differentiating NSC culture 12 hours
before sort. Half of the medium was refreshed with the same
medium in each condition at 4 and 8 days after sorting and then
every 3 days up to two weeks. Addition of BMP-4 was
discontinued from the day 10 after plating. Cells were either fixed
with PFA at 7 days post sort and or have been used for
electrophysiology study at 2 weeks post sort. Different antibodies
including anti-Map-2, anti-NeuN, anti-GAD65/67, anti ChAT,
anti-TH, and anti-DARPP-32 were used to identify the phenotype
of sorted neurons. After taking pictures, cells were quantified and
expressed as a percentage of total neuronal cells counted.
Electrical membrane properties were recorded using the whole-
cell patch clamp recording technique. Patch electrodes were pulled
from borosilicate glass capillaries with resistances of 1.5–3.0 MV
when filled with an intracellular solution containing (in mM): 5
NaCl, 145 KCl, and 10 HEPES-NaOH, pH 7.2. Cells were
maintained in physiological saline solution of the following
composition (in mM): 140 NaCl, 3 KCl, 2 CaCl2, 1 MgCl2, 10
glucose, and 10 HEPES-NaOH, pH 7.4. Experiments were
performed at 20–23uC. Data were acquired at 5–10 kHz using
an Axopatch 200A patch-clamp amplifier and a Digidata 1320
interface (Molecular Devices, Sunnyvale, CA) linked to a personal
computer equipped with pCLAMP 9.0 software and filtered at 2–
5 kHz. The resting membrane potential (RMP) and input
resistance (Rin) was determined from a membrane potential
without current injection and from the steady-state voltage
response to a hyperpolarizing current pulse of 10–50 pA,
respectively. The membrane time constant (tm) was determined
from a single exponential fitted to the voltage response obtained
with the hyperpolarizing current step, and cell membrane
capacitance (Cm) was calculated from Rin and tm. Depolarizing
current pulses of varying amplitude were applied to determine if
action potentials (APs) could be evoked. In the case that no evoked
APs were observed at the RMP, cells were held at 260 mV and
the occurrence of evoked APs was assessed. Data were analyzed
using Clampfit 9.2 and Prism 4.0 (GraphPad, San Diego, CA).
Transplantation
Adult (6–7-weeks of age) male NOD-SCID and C57-Bl6 wild
type mice were anesthetized using 3.5 ml/gr of a five times diluted
mixture of K.X.A (Ketamine (100 mg/ml, 1.5 ml), Xylazine
(20 mg/ml, 1.5 ml) and Ace promazine (10 mg/ml, 0.5 ml).
Immature neurons were prepared as previously described, solely
based on FSC and SSC from differentiating neural stem cells
isolated from tau-GFP E14 mice of C57/Bl6 background. 2 ml of
cell suspension containing 16105 cells in NSC medium alone
(C57/BL6, n = 4 and NOD-SCID, n = 4) or supplemented with
40 ng/ml BMP4 (C57/BL6, n = 4) were injected through a burr
hole using a 5 ml Hamilton syringe (Hamilton Co. USA) over 5
minutes into the right striatum at the following coordinate: A/P
+0.5 mm, Lat 22 mm and D/V 24 mm. Animals were deeply
anesthetized at 4 weeks post transplantation with sodium
pentobarbitone (260 mg/kg), then transcardially perfused with
0.9% saline followed by cold 4.0% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4). Brains were post-fixed in 4% PFA
overnight at 4uC, washed with PBS and cryopreserved in 30%
sucrose in PBS for 24–48 hours. Then, the brains were blocked in
optimal cutting temperature (OCT) on liquid nitrogen and stored
in 280uC freezer until needed.
Brains were cut in a systematic random fashion at 14 mm
thickness with a Leica CM3050 cryostat. Sections were taken as 4
series (collecting every 4th section on each slide) from the
beginning to the end of the striatum and mounted on superfrost
plus slides, dried at room temperature and stored at 220uC until
needed.
Purification of Immature Neuronal Cells
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Microscopy and cell quantification
To evaluate the proliferative potential of transplanted cells, after
performing heat antigen retrieval (retrieval solution, Dako),
immuno-fluorescence staining was performed on a series of
sections in 0.3% PBST solution with 10% normal goat serum
(NGS) containing primary antibodies against GFP (Chicken anti
GFP; abcam, 1/500) and cell proliferative markers such as Ki-67
(Rabbit anti Ki-67; Lieca, 1/500) and MCM2 (Rabbit anti
MCM2; invitrogen, 1/500). Sections were left in primary antibody
solution for 36 hours at 4uC. Then, primary antibody was gently
removed and the sections were washed with PBS. Secondary
antibodies were prepared at appropriate concentrations in PBST
(PBS +0.3% Triton-X) with 10% NGS, and left on sections for
1 hour at room temperature in the dark. After washing, sections
were coverslipped, using Vectashield mounting medium contain-
ing DAPI (Vector Laboratories, CA, USA). Representative images
were taken for each animal using Olympus DSU-IX81confocal
microscope and the percentage of Ki-67 and MCM2 positive cells
out of total GFP/DAPI-IR counted cells were calculated.
To estimate the number of cells survived four weeks after
transplantation, a series of sections (systematic random sections
representing the total transplant region) from each animal was
immunostained for NeuN (Chemicon, 1:150) and GFP (Chicken
anti GFP, AVES lab Inc, 1/500) as previously described. Images
from the entire graft region of each stained section were captured
on a Canon EOS digital camera using an Olympus Axiophot
upright fluorescence microscope. Images were merged together
and the brightness and contrast were adjusted using Adobe
Photoshop CS4. The total number of DAPI stained GFP positive
cells was counted for each section and pooled for each series (gQ_)
then multiplied by the reciprocal of section sampling fraction (1/
SSF) to have an estimate of total cells in each animal (E (N))
(Fractionator method; E (N) =gQ_61/SSF61/ASF61/TSF)
[25]. Area sampling fraction (1/ASF) and thickness sampling
fraction (1/TSF) are equal to one as we counted cells in all graft
area through the entire section thickness. To avoid overestimation,
only GFP-IR cells with clear DAPI positive nuclei were counted.
In the same sections the number of GFP-NeuN positive cells was
quantified and expressed as a percentage of total GFP positive
cells. The NeuN-GFP double labeling was confirmed using a
confocal microscope (Zeiss Meta 510).
Statistical analysis
One-way analysis of variance (ANOVA) or Students t-tests were
used to analyze data as appropriate (Prism 4, Graphpad Software
Inc. USA). Significant ANOVA values were followed by post hoc
comparisons of individual means where applicable. All values are
expressed as mean6standard error of the mean. The level of
significance for all comparisons was p,0.05.
Results
Isolation of immature neuronal cells based on physical
characteristics
To isolate highly enriched immature neurons, we exploited the
morphological differences observed between neurons and glia in
differentiating NSC progeny. Using a modified protocol of
Scheffler et al. (referred to as the neuroblast assay) [22], passaged
NSCs were plated at high density in NSC medium containing 5%
FCS, EGF and b-FGF. After 4 days, the growth factor containing
medium was switched to a growth factor free medium and 4 days
later the NBA exhibited colonies of small b III-tubulin IR cells on
top of a flat GFAP IR cellular monolayer (Fig. 1A–D). Flow
cytometry analysis of single cell suspensions from these differen-
tiating NSC progeny revealed two separate populations (P1 & P2)
based on their physical characteristics (Fig. S1) as defined by FSC
and SSC plots (Fig. 1E and H). After exclusion of doublets or cell
clumps using side scatter pulse width, versus side scatter pulse
height (Fig. 1F) and dead cells as determined by propidium iodide
(PI) uptake (Fig. 1G), analysis of the total live cells ([Fig. 1G]
labeled as P3 in Fig. 1H) revealed that 2462% of the cells were b
III-tubulin IR (Fig. 1I and L), and 43.562.8% were GFAP IR
(Fig. 1I and M). Using size and granularity, single viable cells were
designed as being in the P1 (FSClowSSClow) or P2 (FSChighSSChigh)
population (Fig. 1H), sorted and plated in 96-well plates. One day
later, dual staining for b III-tubulin and GFAP (Fig. 1 I–K,)
demonstrated that 75.263.3% of the cells in the P1 population
were b III-tubulin IR and 0.860.2% were GFAP IR (Fig. 1J, L,
M). In contrast, in the P2 population (i.e. FSChighSSChigh, Fig. 1H)
73.762.7% were GFAP IR and 6.661.2% were b III-tubulin IR
(Fig. 1K, L, M). These results were confirmed by flow cytometry
analysis using differentiating NSC cultures derived from double-
cortin-GFP animal (Fig. S2A–O). In this case, virtually all (,98%)
of the GFP positive cells resided in P1 population (Fig. S2E-K) and
100% of sorted GFP positive cells expressed b III-tubulin (Fig.
S2L-O). Hence, utilization of this strategy allows an enriched
population of immature neurons (.70%) to be separated from
astrocytes based on morphological characteristics using flow
cytometry.
Neurosphere and neural colony forming frequency of
sorted cells
NSC cultures are composed of a heterogeneous population of
differentiated, progenitor and stem cells. While the potential for
undesirable proliferation after implantation of NSCs is low
[26,17] the risk is still present [19,20,3]. Therefore to determine
the precursor and stem cell frequency in our defined populations,
we employed two assays: (1) Neurosphere Assay (NSA) that
provides a readout of precursor cells (including both stem and
progenitor cells) and (2) Neural-Colony Forming Cell Assay (N-
CFCA) enabling quantitative discrimination between stem and
progenitor cells [23]. Cells were isolated from three different
populations (P1, P2 and P3) and cultured in the NSA and the N-
CFCA for 7- and 21-days, respectively. In the NSA the numbers
of spheres were counted (Fig. 2A and C) and the total number
colonies, including large colonies (.2 mm in diameter), were
enumerated in the N-CFCA (Fig. 2B and D). Within the P3 (the
total) population sphere-forming frequency was 1.260.06% while
the P1 and P2 population gave rise to 0.0960.03 and
1.6760.21%, respectively. Similarly, the colony-forming frequen-
cy was 1.560.2%, 0.0760.02%, and 1.9860.2% in the P3, P1
and P2 population, respectively. Hence, the vast majority
(94.761.7%) of the neurosphere forming cells (i.e. stem &
progenitor cells) resided in the P2 population (Fig. 2C). When
plated in the N-CFCA the majority of cells with stem cell
characteristics (colonies.2 mm) resided in the P2 population
(0.03160.007%, compared to the total population, 0.0326
0.003%). Conversely, only a very small percentage of the P1
cells (0.000560.0001%) exhibited this defining stem cell feature
(Fig. 2D). While, the NSC frequency in the total population was
1:3114, it was almost exclusively contained within P2 population
(1:3250), with the NSC frequency of the P1 cells being quite rare
(1:200,000). Hence, using a sorting strategy based solely on FSC
and SSC, nearly 95% of the proliferative precursors and greater
than 96% of the bona fide NSCs could be eliminated from the
NSC progeny thereby decreasing the probability of undesirable
proliferation.
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Figure 1. Differentiating neural stem cell progeny, cell sorting strategy and analysis of different populations post-sorting. (A–D):
Representative micrographs of the neuroblast assay culture, 4 days after switching to growth factor free medium and stained for the astrocyte
marker; GFAP (A), neuronal marker; b III-tubulin (B) and counterstained with DAPI(C). Notice the colonies of b III-tubulin positive neuronal cells on top
Purification of Immature Neuronal Cells
PLoS ONE | www.plosone.org 5 June 2011 | Volume 6 | Issue 6 | e20941
Enrichment of immature neurons with negative selection
While encouraging, purification based on morphological char-
acteristics alone achieved only 75% purity of the neuronal
population. O4 and A2B5 (early oligodendroglial lineage markers
[27]) immunocytochemistry was performed on the sorted P1
population and demonstrated contamination with immature glial
cells (data not shown). Consequently, the P1 population was further
enriched using a negative selection strategy. Double exclusion of O4
and A2B5 IR cells from the P1 population (Fig. S3A–F) increased the
purity of the sorted b III-tubulin IR cells from 75.263.3% to
91.660.93% (Fig. 3A, C–D). The percentage of GFAP IR cells
decreased from 0.860.2% in the sorted P1 population to
0.3860.1% with negative selection, but did not reach statistical
significance (Fig. 3B). The negative selection strategy with detection
of specific surface markers for immature glial cells (O4 and A2B5)
yielded a highly pure immature neuronal cell population.
Isolation of immature neuronal cells based on PSA-NCAM
immunoreactivity
While the negative selection resulted in a highly pure population
(,92%), we further evaluated a positive selection strategy using
PSA-NCAM with the goal of obtaining increased purity. PSA-
NCAM has been used to separate immature neuronal cells from
E13.5 rat neural tubes [28] , to isolate neuronal precursor cells
directly from adult mouse subventricular zone (SVZ) [29], and to
purify ES cell derived neuronal cells using an immunopanning
method [30]. Immunocytochemistry on sorted cells from the P1
population demonstrated PSA-NCAM immunoreactivity in ap-
proximately 60% of the cells (Fig. 3E–G) and appeared to be
localized exclusively to immature neurons. Therefore, to obtain a
more purified population of immature neurons, we isolated PSA-
NCAM IR cells from the P1 population by flow cytometry (Fig.
S3A–D and G, H). Using this approach, the purity of b III-tubulin
IR cells reached near homogeneity, 97.560.44% (Fig. 3H). In
addition, the mean percentage of GFAP IR cells in the PSA-
NCAM+/P1 sorted cells decreased from 0.860.2% with sorting
alone to 0.2360.1% with positive selection, but did not reach
statistical significance (Fig. 3I). In an attempt to reach higher
purity, we sorted PSA-NCAM+ cells from O4 and A2B5 double
excluded P1 cell population. The purity of b III-tubulin IR cells in
this approach reached 97.760.27% but was not significantly
different to the PSA-NCAM+/P1 sorted cells, 97.560.44% (Fig.
S4). PSA-NCAM is expressed prior to b III-tubulin in vivo, which
suggests that PSA-NCAM IR cells are more immature neuronal
cells [28]. Therefore purification of PSA-NCAM cells from the P1
neuronal population allows for isolation of highly enriched and
potentially a more developmentally synchronized immature
neuronal subpopulation.
Screening the survival effect of different factors on
sorted immature neurons
In vitro, neuronal cells require support molecules or growth
factors to enhance their survival and maturation [31]. Following
sorting and plating in tissue culture dishes, the majority of the
immature neurons died within a few days, likely due to the absence
of appropriate support molecules. To address this dilemma, we
tested seven compounds for their ability to promote survival.
These factors included two concentrations of FCS (at 2% and
10%) and five growth factors (BDNF at 100 ng/ml, CNTF at
20 ng/ml, Noggin at 200 ng/ml, GH at 100 ng/ml and BMP-4 at
20 ng/ml (Fig. 4A, B). Growth factors were added once at the time
of plating and cultures were fixed with 4% PFA and dual
immunostained for b III-tubulin and GFAP after 6 days in culture.
The numbers of DAPI-positive, process bearing b III-tubulin IR
cells were evaluated as an indicator of surviving neurons. BMP4
treated immature neurons showed a statistically significant
increase in the number of process bearing b III-tubulin IR cells/
field of view (32.4665.5) at 6 days after plating compared to the
control (8.861.7) group (Fig. 4A, B). Serum, BDNF, CNTF, GH,
and Noggin did not induce a significant change relative to
controls. We confirmed the survival actions of BMP4 on our sorted
neuronal cells by comparing the percentage of dead or dying cells
labeled with PI (22.760.46% vs. 12.460.34%) and analyzed
apoptotic cells as determined by total Annexin–V+/PI+
(24.560.3% vs. 12.160.2%). Furthermore, we investigated the
percentage of cells undergoing apoptosis by comparing Annexin-
V+/PI- (460.56% vs. 2.260.23%) and anti-activated Caspase-3
immunoreactivity (3.760.3% vs. 2.360.1%) in control vs. BMP4
treated cultures, respectively (Fig. S5A–D). In all cases the addition
of BMP4 (20 ng/ml) resulted in a significant reduction in cell
death and apoptosis. It is possible that BMP4 can act as a mitogen
for a small population of cells derived from the P1 population and
increase the number of neurons by proliferation as opposed to
survival, or in addition to survival. However, we feel this is unlikely
for the following reasons: (1) BMP4 has not been reported to have
mitogenic actions on immature neurons, (2) we observed a
significant reduction in dead and dying cells (Fig. S5A–D) that
supports the conclusion that BMP4 is having a survival effect, and
(3) we have seen no overt signs of proliferation in these cultures in
the presence of BMP4 (i.e. no clusters, doublets or signs of dividing
cells). As we have not carried out any BrdU incorporation studies
in the BMP4 treated cultures we cannot completely rule this out.
Taken together, these data demonstrate that sorted immature
neuronal cell survival can be altered with the addition of
appropriate growth factors and that the assay may be useful for
identifying molecules that enhance the survival of immature
neurons.
Immunophenotyping of sorted immature neurons
The addition of BMP4 to the purified sorted neurons
significantly enhanced survival and maturation, allowing us to
investigate the neurotransmitter phenotype. Seven days after
plating (and administration of BMP4 at 20 ng/ml on day 1 and 4)
cells were fixed and dual immunostained for MAP-2 or NeuN
(markers of mature neurons) and GAD65/67(GABAergic),
DARPP-32 (GABAergic), tyrosine hydroxalase (TH-dopaminer-
gic) or choline acetaly transferase (ChAT-cholinergic) to determine
of the astrocyte monolayer (D) and the nucleus size difference. (E–H): Cells were first plotted based on FSC, versus SSC (E) and then side scatter pulse
width (SSC-W), versus side scatter pulse height (SSC-H) (F) to exclude doublets and clumps. After excluding dead or damaged cells based on
Propidium Iodide (PI) uptake (G), cells were plotted based on FSC and SSC (H) and gates drawn to define 3 cell populations; P1 (FSClow SSClow), P2
(FSChigh SSChigh) and P3 (total cells). (I–K): Micrographs of sorted cells from P3 (I), P1 (J), and P2 (K) population that were stained (1 day after plating)
for b III-tubulin, GFAP and DAPI. (L–M): The percentage of b III-tubulin IR (L) and GFAP IR (M) cells was quantified for each of the sorted populations.
Comparing to the total cell population, the vast majority of the P1 population is composed of immature neurons; while very few are in the P2
population. Conversely, the P2 population is enriched with astrocytes, with few found in the P1 population. (mean6SEM; n = 429 independent
experiments; * p,0. 05, *** p,0.0001, one-way ANOVA). Scale bars = 50 mm. Abbreviations: GFAP = Glial fibrillary acidic protein, IR = Immunoreactive,
DAPI = 49, 6-Diamidino-2-Phenylindole, FSC; Forward Scatter, SSC; Side Scatter, ANOVA; analysis of variances.
doi:10.1371/journal.pone.0020941.g001
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the neuronal phenotype. The majority of the cells (greater than
80%) expressed MAP-2 or NeuN suggesting the immature neurons
were expressing a more mature phenotype (data not shown). The
predominant neuronal phenotype for NSCs expanded as neuro-
spheres is GABAergic [32], hence, it was not surprising that we
saw no immunoreactivity for TH or ChAT but did observe that
virtually all of the MAP-2 IR cells (i.e mature neurons) were
GAD65/67 IR (98.3561.5%). Similarly, all of the MAP-2 IR cells
were DARPP-32 IR (99.860.1%), a marker of medium spiny
neurons (Fig. S6A, B). Based on these results, neuronal cells sorted
as described above, can survive and mature with the addition of
BMP4, and are predominantly GABAergic medium spiny
neurons.
While we noted a significant survival effect on the predomi-
nately GABAergic neurons in the BMP4 cultures, there was still a
large amount of cell death. This suggests some degree of
heterogeneity in the neuronal P1 population and that BMP4 does
not have a survival effect on all GABAergic neurons derived from
the Neurosphere Assay.
Electrophysiological Properties of Sorted Neurons
Although immunocytochemistry suggested that the neurons
would mature in culture, their utility for transplantation lay in
their functional capabilities. Therefore, we investigated whether
sorted immature neurons could reach functional maturation by
using patch clamp electrophysiology. Three culture conditions
were used: (1) complete NSC medium with BMP4, (2) astrocyte
conditioned medium (CM-See the methods) and (3) CM plus
BMP4. Following maturation under the three conditions for 2
weeks the cells were switched to a physiologic solution and
Figure 2. Frequency of stem and progenitor cells in the sorted populations using the NSA and N-CFCA. (A): Representative spheres
from sorted cells, 7 days after plating in NSA culture. (B): Typical large colony (.2.0 mm) that is derived from a NSC, 21 days after plating in the N-
CFCA. (C–D): Comparing the means of the sphere forming frequency in the NSA (C) and large colony (.2 mm) frequency in the N-CFCA (D) of cells
sorted from the P1, P2 and P3 population. The majority of neural stem and progenitor cells can be removed from the neuronal cell population (P1),
sorting based on FSC and SSC properties. (mean6SEM; n = 326 independent experiments; *** p,0.0001, one way ANOVA). Scale bars = 50 mm for A
and 250 mm for B. Abbreviations: NSA = Neurosphere assay, N-CFCA = neural- colony forming cell assay.
doi:10.1371/journal.pone.0020941.g002
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Figure 3. Negative and positive selection strategies to further improve neuronal cell enrichment. In order to achieve purer neuronal cell
population, contaminating cells (O4 and/ A2B5+cells) were excluded from P1 population or PSA-NCAM+ cells were selected and isolated from the P1
population. (A): Comparison of the mean percentage of b III-tubulin IR cells from the sorted P1 vs. O4/A2B5 double excluded P1 cell population one
day after plating. (mean6SEM; n = 529 independent experiments; ** p = 0.0038, Student’s t-test,). (B): Comparison of the mean percentage of GFAP
IR cells in sorted P1 vs. O4/A2B5 double excluded P1 cell population one day after plating. (mean6SEM; n = 529 independent experiments). (C–D):
Micrographs from O4/A2B5 excluded P1 sorted cells showing that the majority of cells are b III-tubulin immunoreactive one day after sort. (E–G): PSA-
NCAM staining on sorted cells from the P1 population one day after plating showing about 60% of sorted cells are PSA-NCAM IR. (H–I) Comparison of
the mean percentage of b III-tubulin (H) and GFAP (I) positive cells in P1 and PSA-NCAM+ P1 sorted cells one day after plating (mean6SEM; n = 529
independent experiments, *** p = 0.0004, Student t-test,). Scale bars = 10 mm. Abbreviation: PSA-NCAM = Polysialic acid-neural cell adhesion
molecule.
doi:10.1371/journal.pone.0020941.g003
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electrical recordings obtained with patch electrodes connected to
the cells and a patch amplifier. Electrophysiological findings
showed that sorted immature neurons could undergo functional
maturation in vitro if provided with supporting culture conditions
(Fig. 4C–E). Table 1 summarizes the electrophysiological
properties of differentiating neurons under the three maturation
conditions tested. Although astrocyte conditioned medium facil-
itated functional maturation of sorted P1 immature neurons by
increasing Na+ channel expression after two weeks in culture, it
was not sufficient to evoke action potentials (APs) from the resting
membrane potential (RMP). While seemingly mature based on
marker expression, they did not function optimally. The addition
of BMP4 (at 20 ng/ml on day 1,4 and 8) to the astrocyte
conditioned medium induced further functional maturation as
evidenced by APs at RMP, whereas BMP4 added to NSC medium
alone had no significant effect on the occurrence of APs (Fig. 4D
and E). Around 75% of the cells treated with a combination of
conditioned medium and BMP4 exhibited repetitive APs from the
RMP (Fig. 4D), which was probably due to increased Na+ and K+
channel current density and a slightly hyperpolarized RMP.
Taken together, culturing the P1 sorted immature neurons in
astrocyte-conditioned medium with BMP4 allows expression of
mature neuronal markers and functional maturity. Furthermore,
these cells could be used as a model to investigate the
electrophysiological properties of maturing neurons.
In vivo survival and maturation
We next assessed the ability of the sorted P1 neuronal cells to
survive and mature following intracerebral implantation. P1
cells derived from a tau-GFP mouse were obtained as noted
above, and implanted into the non-lesioned striatum of adult
wild type C57/Bl6 mice. Four weeks after implanting 100 K
cells, the brains of the transplanted animals were processed to
evaluate the presence of GFP+/DAPI+ cells (i.e. viable
transplanted cells). While significant amounts of autoflourescent
dying or dead cells were identified, we found that a small
percentage of donor cells survived, 0.9460.1%, of which
20.162.6% were NeuN IR, or mature neurons (Fig. 5F and
Fig. S7A–D). The majority of GFP IR cells were confined to the
transplant core and fiber outgrowth was limited. In contrast,
BMP4 treated P1 derived neurons showed an improved survival,
2.6560.52% of total cells implanted, of which 60.264.2%
percent were NeuN IR (Fig. 5A–F). In the BMP4 group, GFP
IR cells exhibited more extensive outgrowth with processes
being sent into the corpus callosum. As shown in vitro, upon
maturation transplanted neuronal cells also acquired GABAer-
gic phenotype by expressing GAD65/67 (Fig. S8A–C). We
could not see any GFAP-IR cells amongst the surviving
transplanted cells after 4 weeks implying that the immature
neuronal cells had already chosen a neuronal fate and addition
of BMP-4 together with implantation did not alter their fate
(Fig. S9A–C). Hence, enriched NSC-derived neuronal popula-
tion are capable of surviving and differentiating into mature
neuronal cells after transplantation if provided with appropriate
supporting factors such as BMP4.
In vivo proliferation capability of P1 population
Although the cells were found to survive in vivo, the potential for
cell proliferation had only been tested in vitro with the NSA and N-
CFCA under conditions that drive growth of precursor cells (i.e.
growth factor supplemented medium). To evaluate in vivo
proliferative potential of sorted immature neurons from P1
population, we transplanted freshly sorted P1 cells from a tau-
GFP mouse into the striatum of immunodeficient mice. Four
weeks after implantation into NOD-SCID animals, in contrast to
the active proliferative zones like the subventricular area (Fig. 6A–
F), only a small fraction of the surviving GFP IR cells were positive
for Ki-67 and MCM2. While 0.2160.12% GFP+/DAPI+ cells
were Ki67 immunoreactive (Fig. 6G–J), 0.2960.17% were positive
for MCM2 (Fig. 6K–N). Hence, the sorted P1 population
exhibited little in vivo proliferation activity.
Discussion
This work is an attempt to purify immature neuronal cells from
a renewable source of NSC progeny based on their size and
internal complexity. Our findings show that immature neurons
have very small cell bodies and nuclei, and are distinguishable
from astrocytes using microscopy (Fig. 1A–D and Fig. S1A–C).
Exploiting these characteristics via flow cytometry, where distinct
cell populations can be separated based on light scatter properties,
we obtained an enriched immature neuronal population that
developed a GABAergic phenotype and was minimally contam-
inated with glial cells. Further enrichment, to near homogeneity
(97%), was achieved based on a negative (eliminate O4+ & A2B5+
cells) or positive (PSA-NCAM+) selection. These immature
neurons are sensitive to their environmental conditions and are
not very robust, however, their survival and maturation, both in
vitro and in vivo, could be enhanced by exposure to BMP4.
Neuronal cells have been enriched from primary brain tissue
based on cell size [33], transgene [31] and PSA-NCAM expression
[29]. While these approaches provide enriched populations of cells
for pre-clinical studies, they are limited in their clinical application
due to supply and ethical issues of harvesting donor tissue from
primary human cells. ES cells represent a viable alternative, and
flow cytometry has been used together with transgene expression
to derive purified neuronal populations with attenuated tumor
forming ability [34,35]. This has also been combined with
immunopanning for PSA-NCAM to further enrich the neuronal
population [30]. Although potentially useful as a renewable source
of cells, genetic alteration of donor cells is less than ideal and ES
cells carry an inherent risk of tumor formation that may be
unacceptable for wide clinical application. More recently, induced
Pluripotent Stem Cells (iPS) [36] have been used to generate
neural cells [37] that may serve as a more ethically acceptable
autologous donor population, in particular when induced through
non-genetic methods via a transient neural stem cell population
[38].
One of the risks in using any renewable precursor population
as a donor source of cells is the potential for uncontrolled or
unwanted proliferation. Recently, it has been proposed that NSC
progeny are the in situ source of gliomas [39] and that extensive
culture of adult stem cells may generate malignant phenotypes
[40,41] While this is countered by a detailed study of extensively
passed adult NSCs demonstrating their genetic stability, resilience
to transformation and inability to form tumors in immunocom-
promised mice [17], a report by Amariglio and colleagues of a
pediatric patient who had received repeated intracerebellar and
intrathecal injections of large numbers of primary fetal CNS cells,
and presented four years later with a well differentiated benign
glioneuronal neoplasm, suggests a more cautious approach.
While the tumor was likely the result of the large number of
neural progenitor cells [42], the presence of NSCs within the
slurry of donor cells and the resultant undesired growth (although
not transformed nor malignant) raises concern and the need for
more defined populations of cells for transplantation. Our sorted
P1 population was not only highly enriched with immature
neuronal cells but also contained a precursor population (include
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stem cells and progenitor cells) of approximately 1:1111 cells,
which contrasts the 1:83 precursor cell frequency in the overall
population, representing a 13 fold reduction. More importantly
though was the change in the bona fide stem cell population
(based on the N-CFCA [23]) where its frequency was reduced
from 1:3114 to 1:200,000, a 64-fold change. While we were
unable to eliminate all of the stem or precursor cells, the
reduction may be functionally important. To test this we
implanted 100,000 cells from our P1 population (derived from
a tau-GFP transgenic) into NOD/SCID animals and 4-weeks
later counted the number of DAPI+/GFP expressing cells that
were immunoreactive for Ki-67 or MCM2. A very small
population of cells was found to express Ki-67 or MCM2
(0.2160.12% and 0.2960.17%, respectively), revealing that
our sorting procedure did not eliminate all cells with
a proliferative potential. This contrasted the results of Yan
et al.[19] who reported that 3–5% of their NSC progeny
expressed Ki-67, 3–6 months post-implantation. While a small
fraction of cells retained the ability to proliferate we observed no
clusters of proliferation, proliferative rosettes or masses of cells
that would indicate delirious uncontrolled growth, rather the few
cells we noted (1 out of 400) were randomly scattered around the
remaining surviving cells. It is important to note that these data
were generated using only the P1 population (FSClowSSClow)
without additional negative or positive selection and a further
reduction in the number of dividing cells may be achieved by
employing these additional purification strategies.
Our findings demonstrated that addition of BMP4 (at 20 ng/ml)
to our sorted immature neurons increases their survival and is
consistent with the report by Lim and colleagues [43] who
reported that BMP4 increased the survival of purified immature
neuroblasts from dissociated SVZ cultures. Furthermore, it has
been shown that in the olfactory bulb, high concentration of
BMP4 inhibits proliferation of neuronal progenitors, promotes
their exit from the cell cycle and initiates differentiation. In
addition, BMP4 promotes glial differentiation of progenitor cells
from the forebrain subventricular zone [44] and CNS derived
tumor cells [45].
Treatment of sorted P1 population with BMP4 did not
increase the number of GFAP IR cells after six days of culture
(data not shown), nor did we observe any GFAP positive cells 4
weeks after transplantation into the adult striatum of BMP4
treated P1 cells. This suggests the P1 cells are committed to
neuronal fate and that BMP4 enhances their maturation and
survival as demonstrated by an increase in the percentage of
NeuN IR cells in BMP4 treated transplanted P1 cells, relative to
controls. Our electrophysiological data support the role of
BMP-4 in supporting functional maturation (showing action
potential from RMP or establishment of Na+ channels in cell
membrane).
Application of this methodology for purification of a defined
population of highly enriched immature neuronal cells from a
heterogeneous population of human NSC progeny provides a
renewable source of cells that may have potential for in vitro studies
such as drug screening, neurotoxicolgy, electrophysiology and to
act as a source of cells for implantation to repair the injured CNS.
However, additional work still needs to be carried out to
determine if the purified implanted donor cells are able to
functionally integrate. There are many research studies showing
therapeutic application of neural stem and progenitor cells in
animal models of diseases including reduction in seizure activity
[46,47], alleviating neuropathic pain and restoring disrupted
Table 1. Electrophysiological properties of differentiating neurons.
NSC medium+BMP-4 Conditioning medium (CM) CM+BMP-4
Resting membrane potential (mV) 44.162.7 (5) 44.261.7 (7) 49.161.7 (11)
Input resistance (MV) 315696 (5) 514651 (7) 517677 (11)
Membrane time constant (ms) 9.761.4 (5) 20.364.8 (7) 21.862.9 (11)
Membrane capacitance (pF) 37.065.9 (5) 38.166.0 (7) 46.566.3 (11)
Action potential amplitude (mV) 47.0 (1) 60.465.4 (5) 73.963.9 (11)
Action potential frequency (Hz)a ND 37.661.3 (3) 35.364.7 (10)
Na+ channel current (pA/pF)b 29.166.0 (4) 257.4616.2 (5) 2103.3612.1 (8){***
K+ channel current (pA/pF)c 2133.4643.6 (4) 2167.4636.6 (5) 2238.0652.5 (8)
Data are shown as mean6SEM, with number of cells analyzed in parentheses.
aCalculated from 1st and 2nd action potentials in response to a 90 pA depolarizing current step.
bTetrodotoxin-sensitive transient inward current in response to a depolarizing voltage step of 220 mV from a holding potential (HP) of 280 mV.
cTetraethylammonium-sensitive outward current in response to a depolarizing voltage step of +50 mV from a HP of 280 mV. ND; not determined.
***P,0.001; versus the NSC medium+BMP4 group.
{P,0.05; versus the CM group by one-way ANOVA.
doi:10.1371/journal.pone.0020941.t001
Figure 4. Sorted immature neurons survive in vitro and reach functional maturity. Immature neurons were sorted from P1 (FSClow SSClow)
population and plated in various culture conditions to find supportive factors that can increase their survival and functional maturity. (A): Comparison
of the survival effects of different factors on the sorted immature neurons 6 days after plating (mean6SEM; n = 4 independent experiments,
* P = 0.0205, one-way ANOVA on log transformed data). (B): Representative micrographs from different conditions on day 6 after plating. BMP4
treated condition showed the greatest number of process bearing b III-tubulin IR cells/field of view. (C): Depolarizing current injection-induced
repetitive action potentials from a RMP of differentiating neurons cultured in astrocyte conditioned medium plus BMP-4 (20 ng/ml). (D): Effect of
various culture conditions on action potential (AP) occurrence (n$5). APs were evoked with depolarizing current injections, and cells were divided
into three groups; cells with APs from a RMP, with APs only from a hyperpolarized holding potential (HP) of 260 mV and without APs. (E): I–V
relationship of voltage-gated, tetrodotoxin-sensitive Na+ channel current of differentiating neurons under various culture conditions (n$4). Series
resistance (Rs) compensation was not applied. A voltage error of ,10 mV was estimated for the maximum Na+ channel current amplitude given Rs of
2–5 MV. Scale bar = 50 mm. Abbreviations: RMP = resting membrane potential, BMP-4 = Bone morphogenetic protein-4.
doi:10.1371/journal.pone.0020941.g004
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Figure 5. BMP-4 treatment of sorted P1 population improves their survival in adult mouse striatum. Freshly sorted cells P1 cells were
resuspended in medium supplemented with 40 ng/ml of BMP-4 at a density of 56104 cells/ml (2 ml /animal) and injected into the right striatum of
intact C57-BL6 mice and their survival was analysed 4 weeks later. (A–D): Representative micrographs from BMP4 group show that some of the
implanted immature neurons survived and expressed the mature neuronal marker; NeuN. (E): Confocal micrograph from the same group shows some
GFP-NeuN immunoreactive cells. (F): Bar graph shows the percentage of survived Tau-GFP and NeuN-IR cells in control and BMP4 groups as of total
cells (16105 cells/animal) transplanted (mean6SEM; n = 4 animals/group, * P,0.05, ***P = 0.0002, Student’s t-test). Scale bars = 20 mm. Abbreviation:
NeuN = Neuronal nuclei.
doi:10.1371/journal.pone.0020941.g005
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neuronal circuitry in spinal cord injury [48,49], increasing axonal
sprouting in neonatal hypoxic ischemic brain injury [50], and
delaying onset and progression of amyotrophic lateral sclerosis
(ALS) [51]. Applying the methodology developed in this study to
human neural stem cells, we hope to be able to define the starting
population of donor cells (e.g. 60% neurons, 40% glia or 90%
neurons and 10% glia) which may provide the opportunity to
determine the cell type(s) responsible for a phenotypic change, to
investigate the potential mechanisms, and adjust dosing strategies
based on a particular disease or disease stage. Application of
Figure 6. Representative confocal micrographs of sorted Tau-GFP positive immature neurons (P1 population) in NOD-SCID mouse
striatum. (A–C): Ki-67 and (D–F): MCM2 immunoreactive cells of the subventricular zone serve as an internal positive control. Co-localization of
immunoreactive cells with DAPI shows that Ki67 and MCM2 are exclusively nuclear staining. (G–J) Ki-67 staining in transplant region shows a Ki-67+/
GFP2 cell (arrow). (K–N) MCM2 staining in transplant region shows a MCM2
+/GFP+ cell (arrow) and two GFP+ cells that do not have DAPI+ nuclei but
show red fluorescence (arrow head). The auto-fluorescent figures are probably clumps of dying or dead cell that show auto-fluorescence even before
staining. Scale bars = 20 mm for A–F, and 10 mm for G–N. Abbreviations: GFP = Green fluorescent protein, MCM2 = Mini-chromosome maintenance
protein.
doi:10.1371/journal.pone.0020941.g006
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supportive factors that increase survival of the immature neurons
after transplantation, in particularly when used together with a
permissive vehicle such as a 3-dimensional matrix, may increase
the practical application of NSC as a source of donor material for
cell replacement therapies.
Supporting Information
Figure S1 Representative micrographs show sorted
cells with different morphologies. (A–C): Sorted neurons
(P1 population) (A) have a small cell body and nucleus, relative to
astrocytes (P2 population) (B) which have a larger cell body and
nucleus. Oligodendrocytes (C) have a wider range of sizes in their
cell body and nucleus comparable to those of astrocytes and
neuronal cells and are scattered both in P1 and P2 population.
Scale bars = 10 mm.
(TIF)
Figure S2 Representative micrographs and sort plots for
differentiating doublecortin-GFP neural stem cell proge-
ny. (A–D): Micrographs of neuroblast assay on day 4 after switching
to growth factor free medium; Phase (A), Doublecortin-GFP (B), b
III-tubulin immunostained (C) and Merged micrograph (D). Notice
the colonies of b III-tubulin positive neuronal cells (A–D) and co-
localization of b III-tubulin and GFP- IR cells (D). (E–K): Cells were
first plotted based on FSC, versus SSC (E) and then side scatter
pulse width (SSC-W), versus side scatter pulse height (SSC-H) (F) to
exclude doublets and clumps. After excluding dead or damaged cells
based on PI uptake (G), cells were plotted using FSC and SSC (H) to
gate the P1 (FSClow SSClow), P2 (FSChigh SSChigh) and P3 (total)
populations. Control gates were set using non-GFP expressing, wild-
type control cultures in the NeuroBlast Assay (I) and then applied to
doublecortin-GFP cells to locate positive staining cells (J). Back-
gating doublecortin-GFP cells in a FSC and SSC plot revealed that
almost all (98%) of GFP+ cells are in P1 population suggesting that
immature neuronal cells can be isolated from the overall population
based on FSC and SSC properties. (L–O): Representative
micrographs of sorted GFP cells demonstrating that 100% of GFP
IR cells (l) were b III-tubulin IR confirming their neuronal identity
(M–O). Scale bars = 20 mm. Abbreviation: PI = Propidium Iodide.
(TIF)
Figure S3 Negative and positive flow cytometry selec-
tion approaches to increase neuronal cell enrichment. In
order to increase neuronal purity, contaminating cells (O4 and/
A2B5+cells) were excluded from P1 population or PSA-NCAM+
cells were selected and sorted from the P1 population. (A–D): Cells
were first plotted based on FSC, versus SSC (A), then side scatter
pulse width (SSC-W), versus side scatter pulse height (SSC-H) to
exclude doublets and clumps (B). After excluding dead or
damaged cells based on Propidium Iodide (PI) uptake (C), single
viable cells were plotted based on FSC and SSC (D) and gates set
to define the P1 (FSClow SSClow), and P2 (FSChigh SSChigh)
populations. From the P1 population, appropriate gates were set
using a negative control sample (Isotype control antibody) (E, G).
O4 and A2B5, were used to identify glial precursors in the P1
population (F), while PSA-NCAM was used to identify the
immature neurons (H) within the P1 population.
(TIF)
Figure S4 Sorting PSA-NCAM+ cells from P1 population
versus PSA-NCAM+ cells from O4&A2B5 double exclud-
ed P1 population. Comparison of the mean percentage of b III-
tubulin IR cells in sorted PSA-NCAM+ cells from P1 vs. sorted
PSA-NCAM+ cells from O4/A2B5 double excluded P1 cell
population one day after plating. This data shows that combining
negative (O4&A2B5 double exclusion) and positive (PSA-NCAM+
cell selection) sorting strategies does not further increase the purity
of neuronal cells comparing to sorting PSA-NCAM+ cells directly
from P1 cell population (mean6SEM; n = 325 independent
experiments).
(TIF)
Figure S5 Cell death in control versus BMP4 treated
immature neuronal cells. (A–D): One day after plating in
medium only or medium supplemented with 20 ng/ml of BMP4,
sorted P1 cells were labeled for Annexin-V, active caspase-3, b-III
tubulin and PI and the percentage of dead or dying cells was
quantified using flow cytometry. (A) Percentage of PI+ cells is
significantly reduced in the BMP4 treated cultures (mean6SEM;
n = 426 experiments/condition; ***p,0.0001). (B) Similarly the
percentage of cells staining positive for Annexin-V is significantly
reduced in the BMP4 treated cells (mean6SEM; n = 426
experiments/condition; ***p,0.0001,). (C) A comparison of live
cells (PI-) find a significant reduction in Annexin-V binding in the
BMP4 containing cultures (mean6SEM; n = 426 experiments/
condition; **p,0. 05), (D) while an analysis of the b-III-tubulin
expressing cells finds that the addition of BMP4 produces a
significant reduction in the percentage of cells immunoreactive for
activated caspase-3 (an early marker of apoptosis) (mean6SEM;
n = 5 experiments/condition; ** p,0. 05). Together, these data
support the conclusion that BMP4 has a survival effect on
immature neurons sorted from the P1 population. Abbreviations:
PI = Propidium Iodide.
(TIF)
Figure S6 Immunophenotyping of sorted immature
neurons. P1 sorted neuronal cells were differentiated in astrocyte
conditioned medium supplemented with 20 ng/ml of BMP-4 in
order to identify their phenotype. (A): Representative micrographs
from differentiated P1 sorted neuronal cells 7 days after plating.
(B): Graph showing the percentage of GAD 65/67 and DARPP-
32 IR cells out of total MAP-2 IR cells after 7 days differentiation
in astrocyte conditioned medium supplemented with 20 ng/ml
BMP4 (mean6SEM, n = 3 independent experiments). No other
neuronal phenotypes (i.e. Dopaminergic, Cholinergic) were
detected. Scale bars = 10 mm. Abbreviations: BMP-4 = Bone
morphogentic protein-4, GAD 65/67 = Glutamic acid decarbox-
ylase 65/67, DARPP-32 = Dopamin and cAMP regulated phos-
phoprotein-32, Map-2 = Microtubule associated protein-2.
(TIF)
Figure S7 Sorted P1 cells implanted into the intact adult
mouse striatum. Freshly sorted cells from P1 population were
resuspended in NSC medium at a density of 56104 cells/ml and
injected (2 ml /animal) into the right intact striatum of C57-BL6
mice. Cell survival and maturation was analysed 4 weeks later. (A–
D): Representative micrographs from the transplant region
demonstrated that the majority of the implanted cells (GFP+) (A)
And approximately 1% of the implanted cells (arrows) survived, of
which roughly 20% expressed NeuN (B–D), a mature neuronal
marker (see figure 5F for quantitative data). Scale bar = 20 mm.
(TIF)
Figure S8 Sorted P1 cells give rise to GABAergic
neurons after implantation into the adult mouse stria-
tum. (A–C) Representative confocal micrographs illustrate that
implanted P1 neuronal cells (A, green) that were treated with
BMP4 survive and acquire GABAergic phenotype by expressing
GAD65/67 (B; red and c, merged) 4 weeks post implantation.
Scale bar = 20 mm.
(TIF)
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Figure S9 Sorted P1 cells do not differentiate into
astrocytes after implantation into the adult mouse
striatum. (A–C): Representative confocal micrographs show
that implanted BMP4 treated P1 neuronal cells (A, green) survive
but do not differentiate into GFAP expressing cells (B, red) as
evident in the merged picture (C). Scale bar = 20 mm.
(TIF)
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